Eculizumab-Related Abortion in a Woman with Paroxysmal Nocturnal Hemoglobinuria: A Case Report

BACKGROUND: The use of eculizumab during pregnancy has generally been discouraged. Published data on related studies provides conflicting information and establishing a benefit-risk relationship proves to be a complicated task. Miscarriage rates, concomitant medications, and the stages of pregnancy...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Ferreras, Adrián, Velasco-Roces, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928406/
https://www.ncbi.nlm.nih.gov/pubmed/31897393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928406/
https://www.ncbi.nlm.nih.gov/pubmed/31897393

Ejemplares similares